To investigate TRPV1 as a target for impeding NANOG-driven autophagy in cisplatin-resistant tumor cells, we monitored TRPV1 expression in cisplatin-susceptible or -resistant tumor cells. This evidence concerns the gene NANOG and neoplasm.